Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
about
Influence of antidepressants on hemostasisDepression and the Link with Cardiovascular DiseaseClinical impact of selective serotonin reuptake inhibitors therapy with bleeding risksPlatelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese.The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes.Selective serotonin reuptake inhibitors and endothelial function in women.Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart StudyEffects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients.Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma.Review of sertraline in post-traumatic stress disorder.Depression in vascular pathologies: the neurologist's point of view.The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression.Broken heart: depression in cardiovascular disease.Psychobiology of depression/distress in congestive heart failureBleeding incidence with concomitant use of antidepressants and warfarin.Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial.Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good.Negative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, and future directions.Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis.The 'perfect storm' and acute coronary syndrome onset: do psychosocial factors play a role?Depression in patients with heart failure: clinical implications and management.Persistent versus transient depressive symptoms in relation to platelet hyperactivation: a longitudinal analysis of dementia caregivers.Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications.Broken-hearted women: the complex relationship between depression and cardiovascular disease.Impact and clinical management of depression in patients with coronary artery disease.Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome?Hormones, heart disease, and health: individualized medicine versus throwing the baby out with the bathwater.The platelet window: examining receptor regulated second messenger processes in psychosis and depression.Selective Serotonin Reuptake Inhibitors and Operative Bleeding Risk: A Review of the Literature.Inflammation-Associated Co-morbidity Between Depression and Cardiovascular Disease.Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans.Platelet activation and secretion in patients with major depression, thoracic aortic atherosclerosis, or renal dialysis treatment.Nitric oxide: a key player in the relation between cardiovascular disease and major depressive disorder?Hormones, heart disease, and health: individualized medicine versus throwing the baby out with the bathwater.Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment.Increased susceptibility to ventricular arrhythmias in a rodent model of experimental depression.Longitudinal platelet reactivity to acute psychological stress among older men and women.Hypothesis: antiplatelet effects of selective serotonin reuptake inhibitors cause clinical benefits on cardiovascular disease and increase risks of bleeding.
P2860
Q24635625-7CB54842-89F0-4462-9C1C-3536A723CDB7Q26752379-15497D81-62EF-486A-90F0-9B552AA5A815Q28219114-066C51D7-4E71-4991-A9CD-39493D2EE784Q31102771-904E0A1F-8731-4A55-81CD-061B8BC51136Q33312948-5D4A0F8B-4771-43EA-8AA7-7C48A2B81D08Q33868089-7FA68E23-A0D0-4E5F-B30C-37B97058EAD7Q33870796-2474CFAF-6CE9-48E4-8F1F-250F65E32403Q33998929-198C82C0-E256-4138-9CD0-01977806FD67Q34182611-1B7735C9-270D-46CD-AE87-C9F13721473DQ34384552-75A47294-FB1B-4518-BC67-F20E9C95762FQ34655157-D469359F-EFBA-43F0-BCD8-830185DC5FC6Q34974832-30190C83-D1AB-4F18-97D3-0DBB22DEBED0Q35122942-19465C08-DF61-4ED7-8145-240902CB44E2Q35219689-FC33DD85-C930-434E-BDC7-B73DEC7E6770Q35236309-7B422446-F438-4E6D-A6DF-F34D14751B8CQ35293910-07A1BAA4-DCC1-4BD5-8812-E5A064B6DCFBQ35539353-9440E7C4-429E-4C13-BF16-862850A48337Q35662050-FC948474-75C5-4A91-AE9A-00C5FAE73002Q35907475-71E2C79B-8E66-4B56-98EF-873EDBF51B57Q36115552-951F0FEF-B5FF-4D02-B384-25D543176A0CQ36576591-184A8B5F-15F0-4A54-B05F-D21FD6D07484Q36839733-99DC1755-C1FC-43F8-9204-D55EAB985413Q37359620-D90F3579-7C92-4B98-9187-904B78687EDAQ37409451-FC526481-D1D7-460F-8C95-073E5E8AD3A0Q37599875-47D58C09-1659-4B56-AAA5-E9AEF28E5398Q37622990-A35FB546-A45F-4D73-9357-249AEDA00BE9Q37697785-1DB7870C-AA94-48F3-923C-42C8CD8B8428Q37732309-E0E028AA-91CB-447E-A0BF-5D6CD86721C5Q37860257-2AA56571-0823-4DB1-BF5E-72126C8DF0D0Q38777353-F6D91EA3-DA1C-4B28-9980-3E8A84C3613DQ38967657-9325C6F9-8A18-4DC3-9E90-C2E7FFB31C7DQ39004263-CAB2C673-E623-4786-8BD2-A2A80C26BC06Q40006101-06F4D407-EDC7-4C2E-AB27-77BBBF2A4E8AQ40641442-E4ECF21D-7666-45B8-A69E-5FAEEA7696EEQ42415853-78AB36C6-BDD8-44CF-9E22-9DC640F56FE3Q43872474-F40FA2BC-2253-4DDC-9358-E4DBCA75D94FQ44662313-5DE51C0F-ABA8-44B9-AD7F-0108F9F8E164Q44722753-C07F00C4-62D0-424D-AC5B-3D8321964C7CQ46190092-AAB694ED-CC41-43F2-8E4F-F69A89EA38B1Q46740740-855A550E-049A-466F-917B-A6C3045BFAC2
P2860
Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
@en
Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
@nl
type
label
Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
@en
Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
@nl
prefLabel
Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
@en
Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
@nl
P2093
P1433
P1476
Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
@en
P2093
Manatunga A
Musselman DL
Nemeroff CB
Reemsnyder A
P304
P356
10.1001/ARCHPSYC.57.9.875
P407
P577
2000-09-01T00:00:00Z